| Market Cap | ₹268Cr |
| ROE | -18.17% |
| P/E Ratio(TTM) | -0.75 |
| EPS(TTM) | -18.28 |
| P/B Ratio | 0.37 |
| Dividend Yield | 0.00% |
| Industry P/E | 32.40 |
| Book Value | 36.75 |
| Debt to Equity | 0.64 |
| Face Value | 1 |
| Managing Director | Mr. Sanjiv Goyal |
| NSE Symbol | NECLIFE |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 40.96 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.05 | ||
| Wockhardt | NA (0.00%) | -2304.35 | ||
| Natco Pharma | NA (0.00%) | 9.87 |